| Income Statement | 2025-10-31 | 2025-04-30 | ||
|---|---|---|---|---|
| Sales | 0 | - | ||
| General and administrative | 16.102 | 11.453 | ||
| Professional fees | 23.094 | 49 | ||
| Total operating expenses | 39.196 | 60.453 | ||
| Loss from operations | -39.196 | -60.453 | ||
| Interest expense | 10.672 | 5.31 | ||
| Total other expenses | -10.672 | 5.31 | ||
| Net loss before tax provision | -49.868 | -65.763 | ||
| Tax provision | 0 | - | ||
| Net loss | -49.868 | -65.763 | ||
| Basic and diluted | - | 35,327,050 | ||
| Net loss per common share basic and diluted | 0 | - | ||
| Weighted average common shares outstanding - basic and diluted | 38,962,050 | - | ||
Quantumzyme Corp. (QTZM)
Quantumzyme Corp. (QTZM)